{"id":8614,"date":"2023-09-01T13:07:57","date_gmt":"2023-09-01T10:07:57","guid":{"rendered":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/"},"modified":"2023-09-01T13:07:57","modified_gmt":"2023-09-01T10:07:57","slug":"des-medicaments-contre-le-cancer-du-sang-pourraient-permettre-de-guerir-le-vih-selon-des-chercheurs","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/fr\/des-medicaments-contre-le-cancer-du-sang-pourraient-permettre-de-guerir-le-vih-selon-des-chercheurs\/","title":{"rendered":"Les m\u00e9dicaments contre le cancer du sang pourraient permettre de gu\u00e9rir le VIH, selon des chercheurs"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\" class=\"ff-og-image-inserted\" style=\"display:none\"><\/div>\n<p>Tout comme le virus de l&#039;immunod\u00e9ficience humaine (VIH), le cancer du sang constitue une menace s\u00e9rieuse pour la vie d&#039;une personne. Il est int\u00e9ressant de noter qu\u2019une \u00e9tude r\u00e9cente a r\u00e9v\u00e9l\u00e9 que le m\u00e9dicament utilis\u00e9 pour traiter cette maladie pourrait \u00e9galement \u00eatre la cl\u00e9 de la gu\u00e9rison de la premi\u00e8re.<\/p>\n<p>Le m\u00e9dicament en question s&#039;appelle v\u00e9n\u00e9toclax et peut \u00eatre r\u00e9utilis\u00e9 et utilis\u00e9 pour lutter contre l&#039;infection par le VIH, selon les chercheurs australiens \u00e0 l&#039;origine de l&#039;\u00e9tude r\u00e9volutionnaire men\u00e9e par le Walter and Eliza Hall Institute (WEHI) et le Peter Doherty Institute.<\/p>\n<p>De plus, il a \u00e9t\u00e9 d\u00e9montr\u00e9 que le m\u00e9dicament cible les cellules du VIH dormantes ou \u00ab\u00a0hibernantes\u00a0\u00bb, responsables d&#039;infections latentes. Ces cellules latentes du VIH peuvent se cacher dans l&#039;organisme d&#039;un patient, m\u00eame lorsque le virus ne se r\u00e9plique pas activement, et elles constituent l&#039;une des principales raisons pour lesquelles les patients s\u00e9ropositifs ont besoin d&#039;un traitement \u00e0 vie.<\/p>\n<p>Dans un <a rel=\"noopener nofollow\" href=\"https:\/\/www.wehi.edu.au\/news\/could-a-cancer-drug-hold-the-key-to-a-hiv-cure\/\" target=\"_blank\">communiqu\u00e9 de presse<\/a>, le co-premier auteur de l&#039;\u00e9tude, le Dr Philip Arandjelovic de WEHI, a d\u00e9clar\u00e9 que ce m\u00e9dicament particulier suscite la promesse de r\u00e9aliser un nouvel exploit dans la recherche sur le VIH, car &quot;en attaquant les cellules dormantes du VIH et en retardant le rebond viral, le v\u00e9n\u00e9toclax s&#039;est montr\u00e9 prometteur au-del\u00e0 de celui des traitements actuellement approuv\u00e9s&quot;.<\/p>\n<p>\u00ab Chaque r\u00e9ussite visant \u00e0 retarder la r\u00e9apparition de ce virus nous rapproche de la pr\u00e9vention de la r\u00e9apparition de la maladie chez les personnes vivant avec le VIH. Nous esp\u00e9rons que nos r\u00e9sultats constituent un pas vers cet objectif \u00bb, a ajout\u00e9 Arandjelovic.<\/p>\n<p>La recherche a une importance mondiale, avec 39 millions de personnes diagnostiqu\u00e9es s\u00e9ropositives dans le monde. En Australie notamment, 98% de personnes s\u00e9ropositives <a rel=\"noopener nofollow\" href=\"https:\/\/studyfinds.org\/blood-cancer-drug-venetoclax-hiv\/\" target=\"_blank\">maintenir des niveaux de virus ind\u00e9tectables<\/a> gr\u00e2ce \u00e0 un traitement antir\u00e9troviral (TAR) continu, mais l\u2019arr\u00eat du traitement r\u00e9active rapidement les cellules dormantes du VIH. Cela souligne l\u2019importance cruciale d\u2019un traitement coh\u00e9rent contre le VIH.<\/p>\n<p>\u00ab Cela indique que le v\u00e9n\u00e9toclax tue s\u00e9lectivement les cellules infect\u00e9es, qui d\u00e9pendent de prot\u00e9ines cl\u00e9s pour survivre. Le v\u00e9n\u00e9toclax a la capacit\u00e9 de s&#039;opposer \u00e0 l&#039;une des prot\u00e9ines cl\u00e9s de survie \u00bb, a d\u00e9clar\u00e9 le co-premier auteur de l&#039;\u00e9tude, le Dr Youry Kim de l&#039;Universit\u00e9 de Melbourne, selon le communiqu\u00e9 de presse.<\/p>\n<p>Les chercheurs pr\u00e9voient d\u00e9sormais de transf\u00e9rer leurs r\u00e9sultats vers des essais cliniques.<\/p>\n<p>Publi\u00e9 par Medicaldaily.com<\/p>\n<p><a href=\"https:\/\/www.medicaldaily.com\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find-470736\">Source quotidienne m\u00e9dicale<\/a><\/p>\n<p>","protected":false},"excerpt":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\" class=\"ff-og-image-inserted\"><\/div>\n<p>Tout comme le virus de l&#039;immunod\u00e9ficience humaine (VIH), le cancer du sang constitue une menace s\u00e9rieuse pour la vie d&#039;une personne. Il est int\u00e9ressant de noter qu\u2019une \u00e9tude r\u00e9cente a r\u00e9v\u00e9l\u00e9 que le m\u00e9dicament utilis\u00e9 pour traiter cette maladie pourrait \u00e9galement \u00eatre la cl\u00e9 de la gu\u00e9rison de la premi\u00e8re.<\/p>\n<p>Le m\u00e9dicament en question s&#039;appelle v\u00e9n\u00e9toclax et peut \u00eatre r\u00e9utilis\u00e9 et utilis\u00e9 pour lutter contre l&#039;infection par le VIH, selon les chercheurs australiens \u00e0 l&#039;origine de l&#039;\u00e9tude r\u00e9volutionnaire men\u00e9e par le Walter and Eliza Hall Institute (WEHI) et le Peter Doherty Institute.<\/p>\n<p>De plus, il a \u00e9t\u00e9 d\u00e9montr\u00e9 que le m\u00e9dicament cible les cellules du VIH dormantes ou \u00ab\u00a0hibernantes\u00a0\u00bb, responsables d&#039;infections latentes. Ces cellules latentes du VIH peuvent se cacher dans l&#039;organisme d&#039;un patient, m\u00eame lorsque le virus ne se r\u00e9plique pas activement, et elles constituent l&#039;une des principales raisons pour lesquelles les patients s\u00e9ropositifs ont besoin d&#039;un traitement \u00e0 vie.<\/p>\n<p>Dans un <a rel=\"noopener nofollow\" href=\"https:\/\/www.wehi.edu.au\/news\/could-a-cancer-drug-hold-the-key-to-a-hiv-cure\/\" target=\"_blank\">communiqu\u00e9 de presse<\/a>, le co-premier auteur de l&#039;\u00e9tude, le Dr Philip Arandjelovic de WEHI, a d\u00e9clar\u00e9 que ce m\u00e9dicament particulier suscite la promesse de r\u00e9aliser un nouvel exploit dans la recherche sur le VIH, car &quot;en attaquant les cellules dormantes du VIH et en retardant le rebond viral, le v\u00e9n\u00e9toclax s&#039;est montr\u00e9 prometteur au-del\u00e0 de celui des traitements actuellement approuv\u00e9s&quot;.<\/p>\n<p>\u00ab Chaque r\u00e9ussite visant \u00e0 retarder la r\u00e9apparition de ce virus nous rapproche de la pr\u00e9vention de la r\u00e9apparition de la maladie chez les personnes vivant avec le VIH. Nous esp\u00e9rons que nos r\u00e9sultats constituent un pas vers cet objectif \u00bb, a ajout\u00e9 Arandjelovic.<\/p>\n<p>La recherche a une importance mondiale, avec 39 millions de personnes diagnostiqu\u00e9es s\u00e9ropositives dans le monde. En Australie notamment, 98% de personnes s\u00e9ropositives <a rel=\"noopener nofollow\" href=\"https:\/\/studyfinds.org\/blood-cancer-drug-venetoclax-hiv\/\" target=\"_blank\">maintenir des niveaux de virus ind\u00e9tectables<\/a> gr\u00e2ce \u00e0 un traitement antir\u00e9troviral (TAR) continu, mais l\u2019arr\u00eat du traitement r\u00e9active rapidement les cellules dormantes du VIH. Cela souligne l\u2019importance cruciale d\u2019un traitement coh\u00e9rent contre le VIH.<\/p>\n<p>\u00ab Cela indique que le v\u00e9n\u00e9toclax tue s\u00e9lectivement les cellules infect\u00e9es, qui d\u00e9pendent de prot\u00e9ines cl\u00e9s pour survivre. Le v\u00e9n\u00e9toclax a la capacit\u00e9 de s&#039;opposer \u00e0 l&#039;une des prot\u00e9ines cl\u00e9s de survie \u00bb, a d\u00e9clar\u00e9 le co-premier auteur de l&#039;\u00e9tude, le Dr Youry Kim de l&#039;Universit\u00e9 de Melbourne, selon le communiqu\u00e9 de presse.<\/p>\n<p>Les chercheurs pr\u00e9voient d\u00e9sormais de transf\u00e9rer leurs r\u00e9sultats vers des essais cliniques.<\/p>\n<p>Publi\u00e9 par Medicaldaily.com<\/p>","protected":false},"author":2,"featured_media":8615,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg","fifu_image_alt":"","footnotes":""},"categories":[27],"tags":[],"class_list":["post-8614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Blood Cancer Medication May Unlock HIV Cure, Researchers Find - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/fr\/des-medicaments-contre-le-cancer-du-sang-pourraient-permettre-de-guerir-le-vih-selon-des-chercheurs\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blood Cancer Medication May Unlock HIV Cure, Researchers Find - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"Like human immunodeficiency virus (HIV), blood cancer is a serious threat to a person&#039;s life. Interestingly, a recent study has found that the drug used in treating this condition may also hold the key to curing the former.The drug in question is called venetoclax, and it can be repurposed and used to address HIV infection, according to the Australian researchers behind the groundbreaking study led by Walter and Eliza Hall Institute (WEHI) and The Peter Doherty Institute.Moreover, the drug has been found to target dormant or &quot;hibernating&quot; HIV cells, which are responsible for latent infections. These latent HIV cells can hide in a patient&#039;s system, even when the virus is not actively replicating, and they are a major reason why HIV patients require life-long treatment.In a media release, study co-first author Dr. Philip Arandjelovic of WEHI said this particular drug sparks promise for achieving a new feat in HIV research because &quot;in attacking dormant HIV cells and delaying viral rebound, venetoclax has shown promise beyond that of currently approved treatments.&quot;&quot;Every achievement in delaying this virus from returning brings us closer to preventing the disease from reemerging in people living with HIV. Our findings are hopefully a step towards this goal,&quot; Arandjelovic added.The research has global significance, with 39 million people diagnosed with HIV worldwide. In Australia, in particular, 98% of HIV-positive individuals maintain undetectable virus levels through continuous Antiretroviral therapy (ART), but stopping treatment rapidly reactivates dormant HIV cells. This underscores the crucial importance of consistent HIV treatment.&quot;This indicates that venetoclax is selectively killing the infected cells, which rely on key proteins to survive. Venetoclax has the ability to antagonize one of the key survival proteins,&quot; said study co-first author Dr. Youry Kim of the University of Melbourne, according to the news release.The researchers now plan to move their findings to clinical trials.Published by Medicaldaily.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/fr\/des-medicaments-contre-le-cancer-du-sang-pourraient-permettre-de-guerir-le-vih-selon-des-chercheurs\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-01T10:07:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\/\/urbancare.clinic\/#\/schema\/person\/f286c4d84be896d302aceda3ed7e789c\"},\"headline\":\"Blood Cancer Medication May Unlock HIV Cure, Researchers Find\",\"datePublished\":\"2023-09-01T10:07:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/\"},\"wordCount\":326,\"publisher\":{\"@id\":\"https:\/\/urbancare.clinic\/#organization\"},\"image\":{\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\",\"articleSection\":[\"Medical Daily\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/\",\"url\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/\",\"name\":\"Blood Cancer Medication May Unlock HIV Cure, Researchers Find - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\/\/urbancare.clinic\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\",\"datePublished\":\"2023-09-01T10:07:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage\",\"url\":\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\",\"contentUrl\":\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg\",\"caption\":\"Blood Cancer Medication May Unlock HIV Cure, Researchers Find\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/urbancare.clinic\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blood Cancer Medication May Unlock HIV Cure, Researchers Find\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/urbancare.clinic\/#website\",\"url\":\"https:\/\/urbancare.clinic\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\/\/urbancare.clinic\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/urbancare.clinic\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/urbancare.clinic\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\/\/urbancare.clinic\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/urbancare.clinic\/#\/schema\/person\/f286c4d84be896d302aceda3ed7e789c\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/urbancare.clinic\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\/\/urbancare.clinic\/fr\/author\/urban-care-clinic\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les m\u00e9dicaments contre le cancer du sang pourraient permettre de gu\u00e9rir le VIH, selon des chercheurs - Urban Care Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/fr\/des-medicaments-contre-le-cancer-du-sang-pourraient-permettre-de-guerir-le-vih-selon-des-chercheurs\/","og_locale":"fr_FR","og_type":"article","og_title":"Blood Cancer Medication May Unlock HIV Cure, Researchers Find - Urban Care Clinic","og_description":"Like human immunodeficiency virus (HIV), blood cancer is a serious threat to a person's life. Interestingly, a recent study has found that the drug used in treating this condition may also hold the key to curing the former.The drug in question is called venetoclax, and it can be repurposed and used to address HIV infection, according to the Australian researchers behind the groundbreaking study led by Walter and Eliza Hall Institute (WEHI) and The Peter Doherty Institute.Moreover, the drug has been found to target dormant or \"hibernating\" HIV cells, which are responsible for latent infections. These latent HIV cells can hide in a patient's system, even when the virus is not actively replicating, and they are a major reason why HIV patients require life-long treatment.In a media release, study co-first author Dr. Philip Arandjelovic of WEHI said this particular drug sparks promise for achieving a new feat in HIV research because \"in attacking dormant HIV cells and delaying viral rebound, venetoclax has shown promise beyond that of currently approved treatments.\"\"Every achievement in delaying this virus from returning brings us closer to preventing the disease from reemerging in people living with HIV. Our findings are hopefully a step towards this goal,\" Arandjelovic added.The research has global significance, with 39 million people diagnosed with HIV worldwide. In Australia, in particular, 98% of HIV-positive individuals maintain undetectable virus levels through continuous Antiretroviral therapy (ART), but stopping treatment rapidly reactivates dormant HIV cells. This underscores the crucial importance of consistent HIV treatment.\"This indicates that venetoclax is selectively killing the infected cells, which rely on key proteins to survive. Venetoclax has the ability to antagonize one of the key survival proteins,\" said study co-first author Dr. Youry Kim of the University of Melbourne, according to the news release.The researchers now plan to move their findings to clinical trials.Published by Medicaldaily.com","og_url":"https:\/\/urbancare.clinic\/fr\/des-medicaments-contre-le-cancer-du-sang-pourraient-permettre-de-guerir-le-vih-selon-des-chercheurs\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2023-09-01T10:07:57+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg","type":"","width":"","height":""}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_image":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg","twitter_misc":{"\u00c9crit par":"Urban Care Clinic","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/f286c4d84be896d302aceda3ed7e789c"},"headline":"Blood Cancer Medication May Unlock HIV Cure, Researchers Find","datePublished":"2023-09-01T10:07:57+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/"},"wordCount":326,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg","articleSection":["Medical Daily"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/","url":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/","name":"Les m\u00e9dicaments contre le cancer du sang pourraient permettre de gu\u00e9rir le VIH, selon des chercheurs - Urban Care Clinic","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg","datePublished":"2023-09-01T10:07:57+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/09\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find.jpg","caption":"Blood Cancer Medication May Unlock HIV Cure, Researchers Find"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/blood-cancer-medication-may-unlock-hiv-cure-researchers-find\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"Blood Cancer Medication May Unlock HIV Cure, Researchers Find"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"Clinique de soins urbains","description":"Votre clinique de soins m\u00e9dicaux \u00e0 Zanzibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Clinique de soins urbains Zanzibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/f286c4d84be896d302aceda3ed7e789c","name":"Clinique de soins urbains","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/fr\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts\/8614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/comments?post=8614"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts\/8614\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/media\/8615"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/media?parent=8614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/categories?post=8614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/tags?post=8614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}